| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
BACTERIAL PATHOGENESIS |
Department of Structural Biology and Biochemistry, *Department of Population Health Sciences, Hospital for Sick Children, Department of Medicine, Toronto General Hospital, Division of Respiratory Medicine, St Michael's Hospital and Department of Pediatric Laboratory Medicine and Division of Pathology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
Corresponding author: Dr J. Forstner (email: jfforst{at}sickkids.on.ca).
Received 15 Sept. 2000; revised version accepted 23 Nov. 2000.
Abstract
Infection by Burkholderia cepacia is sometimes fatal in patients with cystic fibrosis (CF), as the organism can cause necrotising pneumonia and septicaemia (the cepacia syndrome), and is resistant to antibiotics. To increase knowledge of the pathogenesis of lung infection, the present study investigated the distribution of B. cepacia in lung explants from nine CF recipients of double lung transplants, of which six were colonised with both B. cepacia and Pseudomonas aeruginosa and the other three with P. aeruginosa only. In one case, explants of the donor lung (allograft) became available after the patient succumbed post-operatively to the cepacia syndrome. Further autopsy sections were examined from two patients who had chronic and then acute infection with B. cepacia. A specific antibody reactive with all five genomovars of the B. cepacia complex and another antibody specific for the 22-kDa adhesin of cable pili, were used to localise bacteria in situ. In chronic infection, the organisms were diffusely distributed, but most concentrated in hyperplastic bronchiolar epithelium, inflamed peribronchial and perivascular areas, between adjacent airway epithelial cells and in pathologically thickened alveolar septae and luminal macrophages. In acute infections the distribution was more focal, with B. cepacia on injured airway surfaces and in sites of pneumonia and abscess formation. In autopsy sections from one of the patients with chronic, then acute infection, B. cepacia was also observed in the lumen of blood capillaries. These results suggest that B. cepacia has the capacity to be highly invasive, migrating from the airways across the epithelial barrier to invade the lung parenchyma and capillaries, thereby initiating septicaemia.
This article has been cited by other articles:
|
|
 |
|
  M. S. Saldias and M. A. Valvano Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells Microbiology, September 1, 2009; 155(9): 2809 - 2817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. LiPuma, S. Rathinavelu, B. K. Foster, J. C. Keoleian, P. E. Makidon, L. M. Kalikin, and J. R. Baker Jr. In Vitro Activities of a Novel Nanoemulsion against Burkholderia and Other Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species Antimicrob. Agents Chemother., January 1, 2009; 53(1): 249 - 255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. U. Sajjan, L. A. Carmody, C. F. Gonzalez, and J. J. LiPuma A Type IV Secretion System Contributes to Intracellular Survival and Replication of Burkholderia cenocepacia Infect. Immun., December 1, 2008; 76(12): 5447 - 5455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Simmonds and K. Gyi Cystic fibrosis, a Burkholderia cenocepacia chest wall abscess and rapid clinical deterioration J R Soc Med, July 1, 2008; 101(Supplement_1): 46 - 50. [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Soyza, A. Silipo, R. Lanzetta, J. R. Govan, and A. Molinaro Review: Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides Innate Immunity, June 1, 2008; 14(3): 127 - 144. [Abstract] [PDF]
|
|
|
|
|
|
J. Y. Kim, U. S. Sajjan, G. P. Krasan, and J. J. LiPuma Disruption of Tight Junctions during Traversal of the Respiratory Epithelium by Burkholderia cenocepacia Infect. Immun., November 1, 2005; 73(11): 7107 - 7112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Urban, J. B. Goldberg, J. F. Forstner, and U. S. Sajjan Cable Pili and the 22-Kilodalton Adhesin Are Required for Burkholderia cenocepacia Binding to and Transmigration across the Squamous Epithelium Infect. Immun., September 1, 2005; 73(9): 5426 - 5437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Sajjan, S. Keshavjee, and J. Forstner Responses of Well-Differentiated Airway Epithelial Cell Cultures from Healthy Donors and Patients with Cystic Fibrosis to Burkholderia cenocepacia Infection Infect. Immun., July 1, 2004; 72(7): 4188 - 4199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tomich, A. Griffith, C. A. Herfst, J. L. Burns, and C. D. Mohr Attenuated Virulence of a Burkholderia cepacia Type III Secretion Mutant in a Murine Model of Infection Infect. Immun., March 1, 2003; 71(3): 1405 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Schwab, M. Leigh, C. Ribeiro, J. Yankaskas, K. Burns, P. Gilligan, P. Sokol, and R. Boucher Patterns of Epithelial Cell Invasion by Different Species of the Burkholderia cepacia Complex in Well-Differentiated Human Airway Epithelia Infect. Immun., August 1, 2002; 70(8): 4547 - 4555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Sajjan, G. Thanassoulis, V. Cherapanov, A. Lu, C. Sjolin, B. Steer, Y. J. Wu, O. D. Rotstein, G. Kent, C. McKerlie, et al. Enhanced Susceptibility to Pulmonary Infection with Burkholderia cepacia in Cftr{-}/{-} Mice Infect. Immun., August 1, 2001; 69(8): 5138 - 5150. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |
